TBD   |    TBD

Bringing lung-function testing to the desktop

PulmOne developed an FDA & CE approved desktop device for the measurement of lung volumes that is transforming the diagnosis and identification of lung diseases. Empowering community based physicians to use complete lung function testing in their offices instead of hospitals, PulOne enables a cheaper, faster and more efficient diagnosis, as well as a better patient experience.  PulmOne’s device is already generating commercial orders from leading European distributors.

Thank you to all our partners that made this day possible. They deserve a grand aplause!

Beyond the talks we will feature many events that will give you an opportunity to network.

Meet & Greet, Nametags, Swag, Refreshments

Pecha Kucha Customer Presentations (roughly 7 min each)

Key Speaker Critiquing a local Landing Page

Network with other company users to to share best practices, discuss technical questions, network, and ultimately learn & get inspired from each other.

5:30-6:00 PM

6:00-7:00 PM

7:00-7:10 PM

6:00-7:00 PM

THE PARTNERS

AGENDA

THE COMPANIES

How it works | Our Team | Browse Startups | Blog | News | Offices | Portfolio Reserve 

© Copyright 2016 OurCrowd

TBD

LOCATION

RSVP
OurCrowd

In three years, OurCrowd has grown into a leading startup investing platform, with $200M invested in 90+ companies and a community of over 10,000 accredited investors.

Join us in one of the dozens of cities we are visiting to showcase new startups, display technology from our portfolio companies, and share updates from the Startup Nation.

Join us for OurCrowd's 3rd Annual Global Investor Summit February 15-16, 2017!

Apply for your ticket here

 

 

THE SPEAKERS

Identifying users across devices to improve ROI for digital advertising

Crosswise developed an advanced Big Data analytics technology that identifies online users across their multiple devices, improving ROI for the rapidly growing digital advertising market. Since our last investment in Crosswise, the company has completed development of the product, deployed the product in numerous beta sites, and recently, signed two six-figure paying contract. We are joined in this round by top VCs, Horizons Ventures (Li Ka shing) and Giza Ventures. 

Robotic vision system for laparoscopic surgery

MST developed an advanced video-based laparoscope positioning robotic system for the multi-billion dollar laparoscopic surgery market. Rapid development of the AutoLap system has attracted leading clinical experts in the field of laparoscopic surgery as well as leading investors in the field of life sciences.

Avi Lazar, CEO

PulmOne

Innovative technology bringing lung-function testing to the desktop

Steve Glanz, CEO

Crosswise

Mapping users across devices to improve ROI for digital advertising

Moti Frimer, CEO

MST

Robotic vision system for laparoscopic surgery

We hope to see you in your city soon!
If you are interested in hosting an OurCrowd event, please
contact us.

 

JOIN US AROUND THE WORLD

OurCrowd Events Calendar

InvestOur teamHow it worksEventsBlogOffices
Fix the following errors:
Hide